Krishna Ella

Dr. Krishna Ella
Born
Krishna M. Ella

1969 (age 54–55)
Nemali,Tiruttani, Tamil Nadu, India
EducationPh.D (University of Wisconsin–Madison)
M.S. (University of Hawaiʻi)
M.Sc. (University of Agricultural Sciences, Bangalore)
Occupation(s)Scientist, Entrepreneur
Notable workDevelopment of Covaxin,ROTAVAC, TypbarTCV
TitleExecutive Chairman of Bharat Biotech
Term1996–present
SpouseSuchitra Ella
AwardsPadma Bhushan (2022)

Dr. Krishna Ella is an Indian scientist and entrepreneur. He is the founder and Executive Chairman of Bharat Biotech.[1][2] Ella and his company were responsible for developing India's own COVID-19 vaccine, Covaxin, World's 1st clinically proven conjugated Typhoid Vaccine, TypbarTCV and ROTAVAC.[3][4]

Ella worked as a research faculty at the Medical University of South Carolina in Charleston after earning his Ph.D. from the University of Wisconsin–Madison.[5]

  1. ^ "Here Are 10 Things To Know About Bharat Biotech, Its Founder Krishna Ella". Moneycontrol. Retrieved 9 May 2021.
  2. ^ "Ella, Krishna". Global Health Institute. Retrieved 9 May 2021.
  3. ^ "Krishna Ella: How A Farmer's Son Gave India Its First Successful Indigenous Covid-19 Vaccine". Forbes India. Retrieved 9 May 2021.
  4. ^ Cite error: The named reference :0 was invoked but never defined (see the help page).
  5. ^ "Founder's Profile - Bharat Biotech - A Leading Biotech Company". www.bharatbiotech.com.